Mitogenesis of vascular smooth muscle cell stimulated by platelet-derived growth factor-bb is inhibited by blocking of intracellular Signaling by epigallocatechin-3- O -gallate

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Lee, Mi Hee ^a   Kwon, Byeong Ju ^a,b   Koo, Min Ah ^a,b   You, Kyung Eun ^a,b   Park, Jong Chul ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; SIGNAL TRANSDUCTION;

AKT PHOSPHORYLATION; CARDIO-VASCULAR DISEASE; CELL-CYCLE PROGRESSION; EPIGALLOCATECHIN GALLATE; INTRACELLULAR SIGNALING; SIGNAL TRANSDUCTION PATHWAYS; SIGNALING PATHWAYS; VASCULAR SMOOTH MUSCLE CELLS;

PHOSPHORYLATION;

EPIGALLOCATECHIN GALLATE; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE P38; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KINASE B; PROTEIN P42; CATECHIN; DRUG DERIVATIVE; MITOGENIC AGENT; PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR BB; PROTECTIVE AGENT;

ANIMAL CELL; ARTICLE; CARDIOVASCULAR DISEASE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; INTRACELLULAR SIGNALING; MITOGENESIS; NONHUMAN; PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; AORTA; BIOSYNTHESIS; CELL CYCLE CHECKPOINT; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; HUMAN; INTRACELLULAR SPACE; METABOLISM;

ANIMALS; AORTA; CATECHIN; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; HUMANS; INTRACELLULAR SPACE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MITOGENS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-SIS; RATS; SIGNAL TRANSDUCTION;

EID: 84888877317     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/827905     Document Type: Article

References (53)

1. Willis A. I., Pierre-Paul D., Sumpio B. E., Gahtan V., Vascular smooth muscle cell migration: current research and clinical implications. Vascular and Endovascular Surgery 2004 38 1 11 23 2-s2.0-0942265954 10.1177/ 153857440403800102 (Pubitemid 38140268)
2. Davies M. G., Hagen P. O., Pathobiology of intimal hyperplasia. British Journal of Surgery 1994 81 9 1254 1269 2-s2.0-0028122674 (Pubitemid 24275140)
3. Coats W. D. Jr., Faxon D. P., The role of the extracellular matrix in arterial remodelling. Seminars in Interventional Cardiology 1997 2 3 167 176 2-s2.0-0031216997
4. Schwartz S. M., Smooth muscle migration in atherosclerosis and restenosis. Journal of Clinical Investigation 1997 99 12 2814 2817 2-s2.0-0030925749 (Pubitemid 27278654)
5. Regan C. P., Adam P. J., Madsen C. S., Owens G. K., Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury. Journal of Clinical Investigation 2000 106 9 1139 1147 2-s2.0-0033761131
6. Wang Z., Wang D. Z., Hockemeyer D., McAnally J., Nordheim A., Olson E. N., Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 2004 428 6979 185 189 2-s2.0-1642297200 10.1038/nature02382 (Pubitemid 38374315)
7. Snow A. D., Bolender R. P., Wight T. N., Clowes A. W., Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. The American Journal of Pathology 1990 137 2 313 330 2-s2.0-0025341692 (Pubitemid 20232993)
8. Kraiss L. W., Kirkman T. R., Kohler T. R., Zierler B., Clowes A. W., Shear stress regulates smooth muscle proliferation and neointimal thickening in porous polytetrafluoroethylene grafts. Arteriosclerosis and Thrombosis 1991 11 6 1844 1852 2-s2.0-0026344017
9. Heldin C. H., Westermark B., Mechanism of action and in vivo role of platelet-derived growth factor. Physiological Reviews 1999 79 4 1283 1316 2-s2.0-0032875460 (Pubitemid 29473317)
10. Blank R. S., Owens G. K., Platelet-derived growth factor regulates actin isoform expression and growth state in cultured rat aortic smooth muscle cells. Journal of Cellular Physiology 1990 142 3 635 642 2-s2.0-0025250209
11. Majesky M. W., Reidy M. A., Bowen-Pope D. F., Hart C. E., Wilcox J. N., Schwartz S. M., PDGF ligand and receptor gene expression during repair of arterial injury. Journal of Cell Biology 1990 111 5 I 2149 2158 2-s2.0-0025043810
12. El Bedoui J., Oak M. H., Anglard P., Schini-Kerth V. B., Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression. Cardiovascular Research 2005 67 2 317 325 2-s2.0-21744437098 10.1016/j.cardiores.2005.03.017 (Pubitemid 40943625)
13. Risinger G. M. Jr., Updike D. L., Bullen E. C., Tomasek J. J., Howard E. W., TGF- β suppresses the upregulation of MMP-2 by vascular smooth muscle cells in response to PDGF-BB. The American Journal of Physiology-Cell Physiology 2010 298 1 C191 C201 2-s2.0-73549104265 10.1152/ajpcell.00417.2008
14. Zhan Y., Kim S., Izumi Y., Nakao T., Miyazaki H., Iwao H., Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 5 795 801 2-s2.0-0037625636 10.1161/01.ATV.0000066132.32063.F2 (Pubitemid 36566168)
15. Yamaguchi H., Igarashi M., Hirata A., Tsuchiya H., Susa S., Tominaga M., Daimon M., Kato T., Characterization of platelet-derived growth factor-induced p38 mitogen-activated protein kinase activation in vascular smooth muscle cells. The European Journal of Clinical Investigation 2001 31 8 672 680 2-s2.0-0034864675 10.1046/j.1365-2362.2001.00865.x (Pubitemid 32756615)
16. Cheng X. W., Kuzuya M., Nakamura K., Liu Z., Di Q., Hasegawa J., Iwata M., Murohara T., Yokota M., Iguchi A., Mechanisms of the inhibitory effect of epigallocatechin-3-gallate on cultured human vascular smooth muscle cell invasion. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 9 1864 1870 2-s2.0-24144488315 10.1161/01.ATV.0000179675.49619.9b (Pubitemid 41243455)
17. Kim C. H., Moon S. K., Epigallocatechin-3-gallate causes the p21/WAF1-mediated G1-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF- α -induced vascular smooth muscle cells. Archives of Biochemistry and Biophysics 2005 435 2 264 272 2-s2.0-13544258719 10.1016/j.abb.2004.12.022 (Pubitemid 40222465)
18. Chen D., Milacic V., Chen M. S., Wan S. B., Lam W. H., Huo C., Landis-Piwowar K. R., Cui Q. C., Wali A., Chan T. H., Dou Q. P., Tea polyphenols, their biological effects and potential molecular targets. Histology and Histopathology 2008 23 4 487 496 2-s2.0-42349109175 (Pubitemid 351552334)
19. Maeda K., Kuzuya M., Cheng X. W., Asai T., Kanda S., Tamaya-Mori N., Sasaki T., Shibata T., Iguchi A., Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier. Atherosclerosis 2003 166 1 23 30 2-s2.0-0037212797 10.1016/S0021-9150(02)00302-7 (Pubitemid 35449597)
20. Romano F., Chiarenza C., Palombi F., Filippini A., Padula F., Ziparo E., de Cesaris P., Platelet-derived growth factor-BB-induced hypertrophy of peritubular smooth muscle cells is mediated by activation of p38 MAP-kinase and of Rho-kinase. Journal of Cellular Physiology 2006 207 1 123 131 2-s2.0-33644882817 10.1002/jcp.20554
21. Reusch H. P., Zimmermann S., Schaefer M., Paul M., Moelling K., Regulation of Raf by Akt controls growth and differentiation in vascular smooth muscle cells. The Journal of Biological Chemistry 2001 276 36 33630 33637 2-s2.0-0035823542 10.1074/jbc.M105322200
22. Fredriksson L., Li H., Eriksson U., The PDGF family: four gene products form five dimeric isoforms. Cytokine and Growth Factor Reviews 2004 15 4 197 204 2-s2.0-2942676788 10.1016/j.cytogfr.2004.03.007 (Pubitemid 38781045)
23. Pawson T., Protein modules and signalling networks. Nature 1995 373 6515 573 580 2-s2.0-0028859279
24. Hayashi K., Takahashi M., Kimura K., Nishida W., Saga H., Sobue K., Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. Journal of Cell Biology 1999 145 4 727 740 2-s2.0-0033577854 10.1083/jcb.145.4.727 (Pubitemid 29240851)
25. Bilder G., Wentz T., Leadley R., Amin D., Byan L., O'Conner B., Needle S., Galczenski H., Bostwick J., Kasiewski C., Myers M., Spada A., Merkel L., Ly C., Persons P., Page K., Perrone M., Dunwiddie C., Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF-receptor tyrosine kinase inhibitor, RPR101511A. Circulation 1999 99 25 3292 3299 2-s2.0-0033614838 (Pubitemid 29293441)
26. Noiseux N., Boucher C. H., Cartier R., Sirois M. G., Bolus endovascular PDGFR- β antisense treatment suppressed intimal hyperplasia in a rat carotid injury model. Circulation 2000 102 11 1330 1336 2-s2.0-0034641650
27. Chyu K. Y., Babbidge S. M., Zhao X., Dandillaya R., Rietveld A. G., Yano J., Dimayuga P., Cercek B., Shah P. K., Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation 2004 109 20 2448 2453 2-s2.0-2542446098 10.1161/01.CIR.0000128034.70732.C2 (Pubitemid 38679566)
28. Maron D. J., Lu G. P., Cai N. S., Wu Z. G., Li Y. H., Chen H., Zhu J. Q., Jin X. J., Wouters B. C., Zhao J., Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Archives of Internal Medicine 2003 163 12 1448 1453 2-s2.0-0038677965 10.1001/archinte.163.12.1448 (Pubitemid 36758917)
29. Kim D. W., Park Y. S., Kim Y. G., Piao H., Kwon J.-S., Hwang K.-K., Youn T.-J., Park J. B., Yun Y.-P., Sachinidis A., Kim C.-H., Cho M.-C., Ahn H.-Y., Local delivery of green tea catechins inhibits neointimal formation in the rat carotid artery injury model. Heart and Vessels 2004 19 5 242 247 2-s2.0-5044230087 10.1007/s00380-004-0768-6 (Pubitemid 39335084)
30. Zheng Y., Song H. J., Kim C. H., Kim H. S., Kim E.-G., Sachinidis A., Ahn H. Y., Inhibitory effect of epigallocatechin 3-O-gallate on vascular smooth muscle cell hypertrophy induced by angiotensin II. Journal of Cardiovascular Pharmacology 2004 43 2 200 208 2-s2.0-1642500105 10.1097/00005344-200402000- 00006 (Pubitemid 38129677)
31. Won S. M., Park Y. H., Kim H. J., Park K. M., Lee W. J., Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway. Experimental and Molecular Medicine 2006 38 5 525 534 2-s2.0-33750716841
32. Hwang K. C., Lee K. H., Jang Y., Yun Y. P., Chung K. H., Epigallocatechin-3-gallate inhibits basic fibroblast growth factor-induced intracellular signaling transduction pathway in rat aortic smooth muscle cells. Journal of Cardiovascular Pharmacology 2002 39 2 271 277 2-s2.0-0036146830 10.1097/00005344-200202000-00014 (Pubitemid 34093547)
33. Hofmann C. S., Sonenshein G. E., Green tea polyphenol epigallocatechin-3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53. The FASEB Journal 2003 17 6 702 704 2-s2.0-0037387944
34. Han D. W., Lim H. R., Baek H. S., Lee M. H., Lee S. J., Hyon S.-H., Park J.-C., Inhibitory effects of epigallocatechin-3-O-gallate on serum-stimulated rat aortic smooth muscle cells via nuclear factor- B down-modulation. Biochemical and Biophysical Research Communications 2006 345 1 148 155 2-s2.0-33646401565 10.1016/j.bbrc.2006.04.072
35. Hollman P. C. H., Absorption, bioavailability, and metabolism of flavonoids. Pharmaceutical Biology 2004 42 74 83 2-s2.0-11844285673 10.1080/13880200490893492 (Pubitemid 40093211)
36. Howells L. M., Moiseeva E. P., Neal C. P., Foreman B. E., Andreadi C. K., Sun Y.-Y., Hudson E. A., Manson M. M., Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals. Acta Pharmacologica Sinica 2007 28 9 1274 1304 2-s2.0-34548438445 10.1111/j.1745-7254.2007.00690.x (Pubitemid 47366687)
37. Singh B. N., Shankar S., Srivastava R. K., Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochemical Pharmacology 2011 82 12 1807 1821 2-s2.0-80555123045 10.1016/j.bcp.2011.07.093
38. Ross J. A., Kasum C. M., Dietary flavonoids: bioavailability, metabolic effects, and safety. Annual Review of Nutrition 2002 22 19 34 2-s2.0-0036400016 10.1146/annurev.nutr.22.111401.144957 (Pubitemid 35221452)
39. Kyselova Z., Toxicological aspects of the use of phenolic compounds in disease prevention. Interdisciplinary Toxicology 2011 4 4 173 183 2-s2.0-84857021782 10.2478/v10102-011-0027-5
40. Chow H.-H. S., Cai Y., Hakim I. A., Crowell J. A., Shahi F., Brooks C. A., Dorr R. T., Hara Y., Alberts D. S., Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clinical Cancer Research 2003 9 9 3312 3319 2-s2.0-0042334847 (Pubitemid 37082725)
41. Cheng X. W., Kuzuya M., Kanda S., Maeda K., Sasaki T., Wang Q. L., Tamaya-Mori N., Shibata T., Iguchi A., Epigallocatechin-3-gallate binding to MMP-2 inhibits gelatinolytic activity without influencing the attachment to extracellular matrix proteins but enhances MMP-2 binding to TIMP-2. Archives of Biochemistry and Biophysics 2003 415 1 126 132 2-s2.0-0038172622 10.1016/S0003-9861(03)00221-2 (Pubitemid 36687925)
42. Patra S. K., Rizzi F., Silva A., Rugina D. O., Bettuzzi S., Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts. Journal of Physiology and Pharmacology 2008 59 9 217 235 2-s2.0-64049093215
43. Rodriguez S. K., Guo W., Liu L., Band M. A., Paulson E. K., Meydani M., Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. International Journal of Cancer 2006 118 7 1635 1644 2-s2.0-33644854366 10.1002/ijc.21545 (Pubitemid 43376426)
44. Weber A. A., Neuhaus T., Skach R. A., Hescheler J., Ahn H.-Y., Schrör K., Ko Y., Sachinidis A., Mechanisms of the inhibitory effects of epigallocatechin-3 gallate on platelet-derived growth factor-BB-induced cell signaling and mitogenesis. The FASEB Journal 2004 18 1 128 130 2-s2.0-1342268326
45. Liang Y. C., Chen Y. C., Lin Y. L., Lin-Shaiu S. Y., Ho C. T., Lin J. K., Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3′-digallate. Carcinogenesis 1999 20 4 733 736 2-s2.0-0032804533
46. Zheng X., Chen A., Hoshi T., Anzai J., Li G., Electrochemical studies of (-)-epigallocatechin gallate and its interaction with DNA. Analytical and Bioanalytical Chemistry 2006 386 6 1913 1919 2-s2.0-33751169975 10.1007/s00216-006-0752-3
47. Kitano K., Nam K. Y., Kimura S., Fujiki H., Imanishi Y., Sealing effects of (-)-epigallocatechin gallate on protein kinase C and protein phosphatase 2A. Biophysical Chemistry 1997 65 2-3 157 164 2-s2.0-0030941215 10.1016/S0301- 4622(96)02254-5 (Pubitemid 27199419)
48. Wang Z. Y., Das M., Bickers D. R., Mukhtar H., Interaction of epicatechins derived from green tea with rat hepatic cytochrome P-450. Drug Metabolism and Disposition 1988 16 1 98 103 2-s2.0-0023858287 (Pubitemid 18057103)
49. Sazuka M., Itoi T., Suzuki Y., Odani S., Koide T., Isemura M., Evidence for the interaction between (-)-epigallocatechin gallate and human plasma proteins fibronectin, fibrinogen, and histidine-rich glycoprotein. Bioscience, Biotechnology and Biochemistry 1996 60 8 1317 1319 2-s2.0-0030221731 (Pubitemid 26368099)
50. Sazuka M., Isemura M., Isemura S., Interaction between the carboxyl-terminal heparin-binding domain of fibronectin and (-)-epigallocatechin gallate. Bioscience, Biotechnology and Biochemistry 1998 62 5 1031 1032 2-s2.0-0032062293 (Pubitemid 128473739)
51. Nam S., Smith D. M., Dou Q. P., Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. The Journal of Biological Chemistry 2001 276 16 13322 13330 2-s2.0-0035918278 10.1074/jbc.M004209200
52. Maiti T. K., Ghosh K. S., Dasgupta S., Interaction of (-)-epigallocatechin-3-gallate with human serum albumin: fluorescence, Fourier transform infrared, circular dichroism, and docking studies. Proteins 2006 64 2 355 362 2-s2.0-33745610160 10.1002/prot.20995 (Pubitemid 43993644)
53. Nozaki A., Hori M., Kimura T., Ito H., Hatano T., Interaction of polyphenols with proteins: binding of (-)-epigallocatechin gallate to serum albumin, estimated by induced circular dichroism. Chemical and Pharmaceutical Bulletin 2009 57 2 224 228 2-s2.0-61449110165 10.1248/cpb.57.224